Antibody Responses to Recombinant Epstein-Barr Virus Antigens in Nasopharyngeal Carcinoma Patients: Complementary Test of ZEBRA Protein and Early Antigens p54 and p138
Serological tests based on the antibodies directed against the Epstein-Barr virus early antigen (EA) and viral capsid antigen (VCA), which have been recognized as tumor markers for nasopharyngeal carcinoma (NPC), are routinely used to help in the diagnosis of this malignancy. The detection of these...
Na minha lista:
| Publicado no: | J Clin Microbiol |
|---|---|
| Principais autores: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
2001
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC88313/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11526145/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JCM.39.9.3164-3170.2001 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
